# Angiotensin-II Blockade in Mitral Regurgitation

> **NCT00587470** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 60 (actual)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DRUG:** Candesartan
- **DRUG:** atacand
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00587470
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-08
- **Primary completion:** 2001-08
- **Final completion:** 2001-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00587470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00587470, "Angiotensin-II Blockade in Mitral Regurgitation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00587470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*